IL-1Ra protects hematopoietic cells from chemotoxicity through p53-induced quiescence.
Ye H, Qian L, Zhu S, Deng S, Wang X, Zhu J, Chan GL, Yu Y, Han W.
Ye H, et al.
FASEB J. 2019 Nov;33(11):12135-12145. doi: 10.1096/fj.201900788RR. Epub 2019 Aug 5.
FASEB J. 2019.
PMID: 31373847
Free PMC article.
The rhIL-1Ra may provide a new route for p53-based cyclotherapy, which spares normal cells but kills cancer cells during chemotherapy.-Ye, H., Qian, L., Zhu, S., Deng, S., Wang, X., Zhu, J., Chan, G. L., Yu, Y., Han, W. ...
The rhIL-1Ra may provide a new route for p53-based cyclotherapy, which spares normal cells but kills cancer cells during chemotherapy.-Ye …